CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Ref. TM-TMPK-00184
1mg | 5.163,00 € | ||
100µg | 798,00 € | ||
500µg | 3.085,00 € |
Información del producto
- MS4A-1, CD20, B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 11, Leukocyte surface antigen Leu-16, Bp35, MS4A1
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases. CD20 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in E. coli expression system with C-His-Avi tag. The predicted molecular weight is 16.8 kDa and the accession number is P11836-1.
Propiedades químicas
Consulta técnica sobre: TM-TMPK-00184 CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.